Changes in male breast cancer over a 30-year period

American Surgeon

Volumn 74, Issue 8, 2008, Pages 707-711

  Schaub, Nicholas Paul ^a   Maloney, Nell ^a   Schneider, Heather ^a   Feliberti, Eric ^a   Perry, Roger ^a,b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; ETHNICITY; HUMAN; MALE; MASTECTOMY; MEDICAL RECORD REVIEW; MINIMALLY INVASIVE SURGERY; ORCHIECTOMY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; AGED; BREAST TUMOR; MIDDLE AGED; NONPARAMETRIC TEST; REGISTER; SURVIVAL RATE; UNITED STATES;

AGED; BREAST NEOPLASMS, MALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; VIRGINIA;

EID: 51649092366     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Nahleh ZA. Hormonal therapy for male breast cancer: A different approach for a different disease. Cancer Treat Rev 2006;32:101-105 (Pubitemid 43362231)
3. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005;10:471-479 (Pubitemid 41266328)
4. Bagley CS, Wesley MN, Young RC, et al. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 1987;10:55-60. (Pubitemid 17007908)
5. Walshe JM, Berman AW, Vatas U, et al. A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up. Breast Cancer Res Treat 2007;103:177-183 (Pubitemid 46789139)
6. Meguerditchian AN, Falardeau M, Martin G. Male breast carcinoma. Can J Surg 2002;45:296-302.
7. Anderson WF, Althuis MD, Brinton LA, et al. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 2004;83:77-86.
8. Rayson D, Erlichman C, Suman VJ, et al. Molecular markers in male breast carcinoma. Cancer 1998;83:1947-1955 (Pubitemid 28503726)
9. Gough DB, Donohue JH, Evans MM, et al. A 50-year experience of male breast cancer: Is outcome changing? Surg Oncol 1993;2:325-333
10. Turner L, Swindell R, Bell WG, et al. Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl 1981;63:239-243 (Pubitemid 11125699)
11. Cimmino VM, Degnim AC, Sabel MS, et al. Efficacy of sentinel lymph node biopsy in male breast cancer. J Surg Oncol 2004;86:74-77 (Pubitemid 38580517)
12. Goyal A, Horgan K, Kissin M, et al. Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol 2004;30:480-483 (Pubitemid 38701867)
13. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: A review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 1999;85:629-639
14. Ribeiro G, Swindell R, Harris M, et al. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast 1996;5:141-146 (Pubitemid 26234101)
15. Sandler B, Carmen C, Perry RR. Cancer of the Male Breast. Am Surg 1994;60:816-820 (Pubitemid 24345713)
16. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th Ed, New York: Springer, 2002.
17. Fentiman PS, Fourquet A, Hortobagyi GN. Male breast cancer. Lanc 2006;367:595-604. (Pubitemid 43247575)
18. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538-549 (Pubitemid 23069261)
19. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Canc Epi Bio Prev 2005;15:20-26 (Pubitemid 40165278)
20. Harnden DG, Maclean N, Langlands AO. Carcinoma of the breast and Klinefelter's syndrome. J Med Genet 1971;8:460-461
21. Rosenblatt KA, Thomas DB, McTiernan A, et al. Breast cancer in men: Aspects of familial aggregation. J Natl Cancer Inst 1991;83:849-854
22. Hsing AW, McLaughlin JK, Cocco P, et al. Risk factors for male breast cancer (United States). Cancer Causes Control 1998;9:269-275 (Pubitemid 28319019)
23. Ewertz M, Holmberg L, Tretli S, et al. Risk factors for male breast cancer - a case-control study from Scandinavia. Acta Oncol 2001;40:467-471 (Pubitemid 32682030)
24. Braunstein GD. Gynecomastia. N Engl J Med 1993;328:490-495
25. Goodman MT, Tung KH, Wilkens LR. Comparative epidemiology of breast cancer among men and women in the US, 1996 to 2000. Cancer Causes Control 2006;17:127-136
26. Volpe C, Raffetto JD, Collure DW, et al. Unilateral male breast masses: Cancer risk and their final evaluation and management. Am Surg 1999;65:250-253 (Pubitemid 29114145)
27. Evans GF, Anthony T, Turnage RH, et al. The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J Surg 2001;181:96-100. (Pubitemid 32406299)
28. Chen L, Chantra PK, Larsen LH. Imaging characteristics of malignant lesions of the male breast. Radiographics 2006;26:993-1006.
29. Stalsberg H, Thomas DB, Rosenblatt KA, et al. Histologic types and hormone receptors in breast cancer in men: A population-based study in 282 United States men. Cancer Causes Control 1993;4:143-151 (Pubitemid 23077021)
30. Blin N, Kardas I, Welter C, et al. Expression of the c-erbB2 proto-oncogene in male breast carcinoma: Lack of prognostic significance. Oncology 1993;50:408-411 (Pubitemid 2004034)
31. Albo D, Ames FC, Hunt KK, et al. Evaluation of lymph node status in male breast cancer patients: A role for sentinel lymph node biopsy. Breast Cancer Res Treat 2003;77:9-14. (Pubitemid 36182912)
32. Agrawal A, Cheung KL, Robertson JF. Fulvestrant in advanced male breast cancer. Breast Cancer Res Treat 2007;101:123. (Pubitemid 47555327)
33. Henson DE, Ries L, Freedman LS, Carriaga M. Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer: The basis for a prognostic index. Cancer 1991;68:2142-2149
34. Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997;60:313-319 (Pubitemid 27058403)
35. Giordaro SH, Perkins GH, Broglio K, et al. Adjuvant systemic therapy for male breast cancer. Cancer 2005;104:2359-2364 (Pubitemid 41691556)